Zolmitriptan Spray
Product Images NDC 63629-9575

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Zolmitriptan (NDC 63629-9575). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

A line graph showing the estimated probability of response (%) over time (hours) from the initial dose for zolmitriptan nasal spray at 2.5 mg and 5 mg doses compared to placebo. The graph plots three data series: 2.5 mg nasal spray (circles), 5 mg nasal spray (triangles), and placebo (pluses), with response probabilities increasing over 4 hours.*

FDA Label Image

Figure 2 (Image 02)

A line graph showing the estimated probability (%) of taking an escape medication over 24 hours after the initial dose. It compares three groups: 2.5 mg nasal spray, 5.0 mg nasal spray, and placebo. The x-axis represents hours from the initial dose, and the y-axis represents the estimated probability percentage. The 5.0 mg nasal spray group shows a higher probability curve compared to the 2.5 mg spray and placebo.*

FDA Label Image

Figure 3 (Image 03)

A line graph showing the estimated probability of rescue medication use over 24 hours post dose for zolmitriptan 5 mg nasal spray and placebo. The x-axis represents time post dose in hours, and the y-axis shows the estimated probability percentage. Data points for zolmitriptan (N=231) and placebo (N=253) are plotted, differentiating the two treatments by square and circle markers, respectively.*

FDA Label Image

Figure-a (Image 04)

Illustration showing hands opening a foil packet containing zolmitriptan nasal spray, 5 mg/1, labeled by Bryant Ranch Prepack. The image depicts the action of peeling back the packet to access the nasal spray inside.*

FDA Label Image

Figure B (Image 05)

An instructional illustration showing a woman using one finger to press a nasal spray into one nostril. The image demonstrates proper technique for administering nasal spray medication.*

FDA Label Image

Figure-c (Image 06)

An instructional illustration showing a close-up of a hand holding a zolmitriptan nasal spray device. The image highlights and labels the nozzle and plunger components of the spray. The device label includes the product name 'zolmitriptan Nasal Spray USP 5mg'.*

FDA Label Image

Figure D (Image 07)

An instructional line drawing showing a woman using a nasal spray. She is holding the spray device near her nose, with one finger pointing to the nostril and the other hand pressing the spray actuator. The image is labeled as Figure D and illustrates proper nasal spray administration technique.*

FDA Label Image

Chemical-structure (Image 10)

Chemical structure diagram of zolmitriptan, showing its molecular framework with labeled rings and functional groups consistent with its chemical identity.*

FDA Label Image

Label (Lbl636299575)

Label for Zolmitriptan Nasal Spray, USP, 5 mg strength. The label includes the NDC number 63629-9575-01 and a barcode. It is marked Rx only and features the Bryant Ranch Prepack logo. The label states each spray contains 5 mg of zolmitriptan in a 100-µL aqueous buffered solution, intended for intranasal use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.